002004 Huapont Life Sciences
- 4.59
- -0.02-0.43%
About Huapont Life Sciences Company
The company was founded in 1992 and is a leading enterprise in the field of clinical skin use and skin health in China. It was listed on the Shenzhen Stock Exchange in 2004. After nearly 30 years of hard work, the company has now formed a development pattern with the health industry as the main development direction, and its business scope covers the fields of medicine, medical care, agrochemicals, new materials, tourism, etc. The company is currently a leading clinical skin drug service provider in China, a leading pesticide enterprise, and an industry leader in the field of fine chemical intermediates and new materials. The company's business scope covers five major fields, including medicine, medical care, agrochemicals, new materials, and tourism. The main products include pharmaceutical business, medical business, agrochemical business, new materials business, and tourism business. Corporate honors: High-tech Enterprise, Beijing Enterprise Technology Center, China's Top 100 Pesticide Enterprises, China Petroleum and Chemical Industry Federation Intellectual Property Demonstration Enterprise, China Petroleum and Chemical Industry Federation Intellectual Property Demonstration Enterprise, 2021 China's Top 100 Fine Chemical Enterprises, 2022 Shandong Top 100 Private Enterprise Innovation Top 100, 2023 Shandong Top 10 Industrial “Goose Formation” Cluster Leading Enterprise, etc.
Company Profile
Company Executives
- Name
- Position
- Salary
- songshan zhang
- Chairman, Directors, Core Technical Personnel, Audit Committee Members, Nomination Committee Members, Chairman of the Strategy Committee
- 1.85M
- haian zhang
- Directors, General Manager, Strategy Committee Member, Audit Committee Member
- --
- yunhui peng
- Directors, Board Secretary, Strategy Committee Member, Member of the Remuneration and Assessment Committee
- 847.00K
- rong wang
- Directors
- 1.88M
- zhonghai liu
- Independent Directors, Chairman of the Remuneration and Assessment Committee, Audit Committee Member, Chairman of the Nomination Committee
- 142.90K
- ming li
- Independent Directors, Chairman of the Audit Committee, Member of the Remuneration and Assessment Committee, Nomination Committee Members
- 142.90K
- zhi chen
- Securities Affairs Representative
- --
- zhengjun wang
- Chairman of the Supervisory Board, Auditors
- 780.60K
- qiang bian
- Auditors
- 700.00K
- jian wang
- Chief Financial Officer
- 482.60K
- wenxing wang
- Employee Supervisors
- 226.90K
No Data